nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilazapril—ABCB1—Methylprednisolone—ankylosing spondylitis	0.197	0.279	CbGbCtD
Cilazapril—ABCB1—Betamethasone—ankylosing spondylitis	0.128	0.182	CbGbCtD
Cilazapril—ABCB1—Prednisolone—ankylosing spondylitis	0.126	0.179	CbGbCtD
Cilazapril—ABCB1—Prednisone—ankylosing spondylitis	0.119	0.169	CbGbCtD
Cilazapril—ABCB1—Dexamethasone—ankylosing spondylitis	0.0745	0.106	CbGbCtD
Cilazapril—ABCB1—Methotrexate—ankylosing spondylitis	0.0598	0.0849	CbGbCtD
Cilazapril—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000761	0.00258	CcSEcCtD
Cilazapril—Hypertension—Triamcinolone—ankylosing spondylitis	0.000759	0.00257	CcSEcCtD
Cilazapril—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000758	0.00257	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000754	0.00256	CcSEcCtD
Cilazapril—Myalgia—Triamcinolone—ankylosing spondylitis	0.000749	0.00254	CcSEcCtD
Cilazapril—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000747	0.00253	CcSEcCtD
Cilazapril—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000747	0.00253	CcSEcCtD
Cilazapril—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000744	0.00252	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000742	0.00251	CcSEcCtD
Cilazapril—Flushing—Prednisone—ankylosing spondylitis	0.000741	0.00251	CcSEcCtD
Cilazapril—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00074	0.00251	CcSEcCtD
Cilazapril—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00074	0.00251	CcSEcCtD
Cilazapril—Discomfort—Triamcinolone—ankylosing spondylitis	0.00074	0.00251	CcSEcCtD
Cilazapril—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000738	0.0025	CcSEcCtD
Cilazapril—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000737	0.0025	CcSEcCtD
Cilazapril—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000732	0.00248	CcSEcCtD
Cilazapril—Renal failure—Methotrexate—ankylosing spondylitis	0.00073	0.00248	CcSEcCtD
Cilazapril—Angioedema—Betamethasone—ankylosing spondylitis	0.000729	0.00247	CcSEcCtD
Cilazapril—Angioedema—Dexamethasone—ankylosing spondylitis	0.000729	0.00247	CcSEcCtD
Cilazapril—Angiopathy—Prednisone—ankylosing spondylitis	0.000724	0.00245	CcSEcCtD
Cilazapril—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000722	0.00245	CcSEcCtD
Cilazapril—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000722	0.00245	CcSEcCtD
Cilazapril—Immune system disorder—Prednisone—ankylosing spondylitis	0.000721	0.00244	CcSEcCtD
Cilazapril—Malaise—Dexamethasone—ankylosing spondylitis	0.00072	0.00244	CcSEcCtD
Cilazapril—Malaise—Betamethasone—ankylosing spondylitis	0.00072	0.00244	CcSEcCtD
Cilazapril—Oedema—Triamcinolone—ankylosing spondylitis	0.000718	0.00243	CcSEcCtD
Cilazapril—Vertigo—Dexamethasone—ankylosing spondylitis	0.000717	0.00243	CcSEcCtD
Cilazapril—Vertigo—Betamethasone—ankylosing spondylitis	0.000717	0.00243	CcSEcCtD
Cilazapril—Syncope—Betamethasone—ankylosing spondylitis	0.000716	0.00242	CcSEcCtD
Cilazapril—Syncope—Dexamethasone—ankylosing spondylitis	0.000716	0.00242	CcSEcCtD
Cilazapril—Arrhythmia—Prednisone—ankylosing spondylitis	0.000713	0.00242	CcSEcCtD
Cilazapril—Shock—Triamcinolone—ankylosing spondylitis	0.000706	0.00239	CcSEcCtD
Cilazapril—Insomnia—Prednisolone—ankylosing spondylitis	0.000706	0.00239	CcSEcCtD
Cilazapril—Alopecia—Prednisone—ankylosing spondylitis	0.000705	0.00239	CcSEcCtD
Cilazapril—Shock—Methylprednisolone—ankylosing spondylitis	0.000705	0.00239	CcSEcCtD
Cilazapril—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000703	0.00238	CcSEcCtD
Cilazapril—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000701	0.00238	CcSEcCtD
Cilazapril—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000701	0.00238	CcSEcCtD
Cilazapril—Epistaxis—Methotrexate—ankylosing spondylitis	0.000701	0.00238	CcSEcCtD
Cilazapril—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000701	0.00237	CcSEcCtD
Cilazapril—Tachycardia—Triamcinolone—ankylosing spondylitis	0.0007	0.00237	CcSEcCtD
Cilazapril—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000699	0.00237	CcSEcCtD
Cilazapril—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000696	0.00236	CcSEcCtD
Cilazapril—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000694	0.00235	CcSEcCtD
Cilazapril—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.000693	0.00235	CcSEcCtD
Cilazapril—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000692	0.00235	CcSEcCtD
Cilazapril—Hypertension—Betamethasone—ankylosing spondylitis	0.000689	0.00233	CcSEcCtD
Cilazapril—Hypertension—Dexamethasone—ankylosing spondylitis	0.000689	0.00233	CcSEcCtD
Cilazapril—Myalgia—Dexamethasone—ankylosing spondylitis	0.000679	0.0023	CcSEcCtD
Cilazapril—Myalgia—Betamethasone—ankylosing spondylitis	0.000679	0.0023	CcSEcCtD
Cilazapril—Anxiety—Dexamethasone—ankylosing spondylitis	0.000677	0.00229	CcSEcCtD
Cilazapril—Anxiety—Betamethasone—ankylosing spondylitis	0.000677	0.00229	CcSEcCtD
Cilazapril—Discomfort—Betamethasone—ankylosing spondylitis	0.000671	0.00227	CcSEcCtD
Cilazapril—Discomfort—Dexamethasone—ankylosing spondylitis	0.000671	0.00227	CcSEcCtD
Cilazapril—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000669	0.00227	CcSEcCtD
Cilazapril—Pain—Prednisolone—ankylosing spondylitis	0.000667	0.00226	CcSEcCtD
Cilazapril—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000662	0.00224	CcSEcCtD
Cilazapril—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000659	0.00223	CcSEcCtD
Cilazapril—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000654	0.00222	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000654	0.00222	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000652	0.00221	CcSEcCtD
Cilazapril—Oedema—Betamethasone—ankylosing spondylitis	0.000651	0.00221	CcSEcCtD
Cilazapril—Oedema—Dexamethasone—ankylosing spondylitis	0.000651	0.00221	CcSEcCtD
Cilazapril—Insomnia—Triamcinolone—ankylosing spondylitis	0.000649	0.0022	CcSEcCtD
Cilazapril—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000648	0.00219	CcSEcCtD
Cilazapril—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000645	0.00218	CcSEcCtD
Cilazapril—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000644	0.00218	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000643	0.00218	CcSEcCtD
Cilazapril—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000643	0.00218	CcSEcCtD
Cilazapril—Visual impairment—Methotrexate—ankylosing spondylitis	0.000643	0.00218	CcSEcCtD
Cilazapril—Anaemia—Prednisone—ankylosing spondylitis	0.000642	0.00218	CcSEcCtD
Cilazapril—Shock—Dexamethasone—ankylosing spondylitis	0.000641	0.00217	CcSEcCtD
Cilazapril—Shock—Betamethasone—ankylosing spondylitis	0.000641	0.00217	CcSEcCtD
Cilazapril—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00064	0.00217	CcSEcCtD
Cilazapril—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000638	0.00216	CcSEcCtD
Cilazapril—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000638	0.00216	CcSEcCtD
Cilazapril—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000636	0.00215	CcSEcCtD
Cilazapril—Tachycardia—Betamethasone—ankylosing spondylitis	0.000636	0.00215	CcSEcCtD
Cilazapril—Angioedema—Prednisone—ankylosing spondylitis	0.000635	0.00215	CcSEcCtD
Cilazapril—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000632	0.00214	CcSEcCtD
Cilazapril—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000631	0.00214	CcSEcCtD
Cilazapril—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00063	0.00214	CcSEcCtD
Cilazapril—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00063	0.00213	CcSEcCtD
Cilazapril—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00063	0.00213	CcSEcCtD
Cilazapril—Malaise—Prednisone—ankylosing spondylitis	0.000627	0.00212	CcSEcCtD
Cilazapril—Vertigo—Prednisone—ankylosing spondylitis	0.000624	0.00212	CcSEcCtD
Cilazapril—Syncope—Prednisone—ankylosing spondylitis	0.000623	0.00211	CcSEcCtD
Cilazapril—Tinnitus—Methotrexate—ankylosing spondylitis	0.000622	0.00211	CcSEcCtD
Cilazapril—Anorexia—Betamethasone—ankylosing spondylitis	0.000621	0.0021	CcSEcCtD
Cilazapril—Anorexia—Dexamethasone—ankylosing spondylitis	0.000621	0.0021	CcSEcCtD
Cilazapril—Urticaria—Prednisolone—ankylosing spondylitis	0.00062	0.0021	CcSEcCtD
Cilazapril—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000619	0.0021	CcSEcCtD
Cilazapril—Fatigue—Triamcinolone—ankylosing spondylitis	0.000619	0.0021	CcSEcCtD
Cilazapril—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000617	0.00209	CcSEcCtD
Cilazapril—Pain—Triamcinolone—ankylosing spondylitis	0.000614	0.00208	CcSEcCtD
Cilazapril—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000611	0.00207	CcSEcCtD
Cilazapril—Hypotension—Betamethasone—ankylosing spondylitis	0.000608	0.00206	CcSEcCtD
Cilazapril—Hypotension—Dexamethasone—ankylosing spondylitis	0.000608	0.00206	CcSEcCtD
Cilazapril—Angiopathy—Methotrexate—ankylosing spondylitis	0.000605	0.00205	CcSEcCtD
Cilazapril—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000603	0.00204	CcSEcCtD
Cilazapril—Hypertension—Prednisone—ankylosing spondylitis	0.0006	0.00203	CcSEcCtD
Cilazapril—Chills—Methotrexate—ankylosing spondylitis	0.000599	0.00203	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000593	0.00201	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000593	0.00201	CcSEcCtD
Cilazapril—Myalgia—Prednisone—ankylosing spondylitis	0.000592	0.002	CcSEcCtD
Cilazapril—Arthralgia—Prednisone—ankylosing spondylitis	0.000592	0.002	CcSEcCtD
Cilazapril—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000591	0.002	CcSEcCtD
Cilazapril—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00059	0.002	CcSEcCtD
Cilazapril—Anxiety—Prednisone—ankylosing spondylitis	0.00059	0.002	CcSEcCtD
Cilazapril—Alopecia—Methotrexate—ankylosing spondylitis	0.000589	0.002	CcSEcCtD
Cilazapril—Insomnia—Betamethasone—ankylosing spondylitis	0.000589	0.002	CcSEcCtD
Cilazapril—Insomnia—Dexamethasone—ankylosing spondylitis	0.000589	0.002	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000588	0.00199	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000586	0.00198	CcSEcCtD
Cilazapril—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000585	0.00198	CcSEcCtD
Cilazapril—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000585	0.00198	CcSEcCtD
Cilazapril—Discomfort—Prednisone—ankylosing spondylitis	0.000584	0.00198	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000575	0.00195	CcSEcCtD
Cilazapril—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000573	0.00194	CcSEcCtD
Cilazapril—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000573	0.00194	CcSEcCtD
Cilazapril—Urticaria—Triamcinolone—ankylosing spondylitis	0.00057	0.00193	CcSEcCtD
Cilazapril—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000569	0.00193	CcSEcCtD
Cilazapril—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000569	0.00193	CcSEcCtD
Cilazapril—Oedema—Prednisone—ankylosing spondylitis	0.000567	0.00192	CcSEcCtD
Cilazapril—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000566	0.00192	CcSEcCtD
Cilazapril—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000566	0.00192	CcSEcCtD
Cilazapril—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000566	0.00192	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000562	0.00191	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000562	0.00191	CcSEcCtD
Cilazapril—Fatigue—Dexamethasone—ankylosing spondylitis	0.000561	0.0019	CcSEcCtD
Cilazapril—Fatigue—Betamethasone—ankylosing spondylitis	0.000561	0.0019	CcSEcCtD
Cilazapril—Shock—Prednisone—ankylosing spondylitis	0.000558	0.00189	CcSEcCtD
Cilazapril—Pain—Dexamethasone—ankylosing spondylitis	0.000557	0.00189	CcSEcCtD
Cilazapril—Pain—Betamethasone—ankylosing spondylitis	0.000557	0.00189	CcSEcCtD
Cilazapril—Tachycardia—Prednisone—ankylosing spondylitis	0.000553	0.00188	CcSEcCtD
Cilazapril—Skin disorder—Prednisone—ankylosing spondylitis	0.000551	0.00187	CcSEcCtD
Cilazapril—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000548	0.00186	CcSEcCtD
Cilazapril—Anorexia—Prednisone—ankylosing spondylitis	0.000541	0.00183	CcSEcCtD
Cilazapril—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000539	0.00183	CcSEcCtD
Cilazapril—Anaemia—Methotrexate—ankylosing spondylitis	0.000537	0.00182	CcSEcCtD
Cilazapril—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000537	0.00182	CcSEcCtD
Cilazapril—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000537	0.00182	CcSEcCtD
Cilazapril—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000532	0.0018	CcSEcCtD
Cilazapril—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000532	0.0018	CcSEcCtD
Cilazapril—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000529	0.00179	CcSEcCtD
Cilazapril—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000528	0.00179	CcSEcCtD
Cilazapril—Malaise—Methotrexate—ankylosing spondylitis	0.000524	0.00177	CcSEcCtD
Cilazapril—Vertigo—Methotrexate—ankylosing spondylitis	0.000522	0.00177	CcSEcCtD
Cilazapril—Leukopenia—Methotrexate—ankylosing spondylitis	0.00052	0.00176	CcSEcCtD
Cilazapril—Urticaria—Dexamethasone—ankylosing spondylitis	0.000517	0.00175	CcSEcCtD
Cilazapril—Urticaria—Betamethasone—ankylosing spondylitis	0.000517	0.00175	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000517	0.00175	CcSEcCtD
Cilazapril—Dizziness—Prednisolone—ankylosing spondylitis	0.000516	0.00175	CcSEcCtD
Cilazapril—Asthenia—Triamcinolone—ankylosing spondylitis	0.000515	0.00174	CcSEcCtD
Cilazapril—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000515	0.00174	CcSEcCtD
Cilazapril—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000515	0.00174	CcSEcCtD
Cilazapril—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000514	0.00174	CcSEcCtD
Cilazapril—Insomnia—Prednisone—ankylosing spondylitis	0.000513	0.00174	CcSEcCtD
Cilazapril—Paraesthesia—Prednisone—ankylosing spondylitis	0.000509	0.00173	CcSEcCtD
Cilazapril—Pruritus—Triamcinolone—ankylosing spondylitis	0.000508	0.00172	CcSEcCtD
Cilazapril—Cough—Methotrexate—ankylosing spondylitis	0.000507	0.00172	CcSEcCtD
Cilazapril—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000507	0.00172	CcSEcCtD
Cilazapril—Dyspepsia—Prednisone—ankylosing spondylitis	0.000499	0.00169	CcSEcCtD
Cilazapril—Arthralgia—Methotrexate—ankylosing spondylitis	0.000494	0.00168	CcSEcCtD
Cilazapril—Myalgia—Methotrexate—ankylosing spondylitis	0.000494	0.00168	CcSEcCtD
Cilazapril—Chest pain—Methotrexate—ankylosing spondylitis	0.000494	0.00168	CcSEcCtD
Cilazapril—Decreased appetite—Prednisone—ankylosing spondylitis	0.000493	0.00167	CcSEcCtD
Cilazapril—Rash—Prednisolone—ankylosing spondylitis	0.000492	0.00167	CcSEcCtD
Cilazapril—Dermatitis—Prednisolone—ankylosing spondylitis	0.000492	0.00167	CcSEcCtD
Cilazapril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000491	0.00166	CcSEcCtD
Cilazapril—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00049	0.00166	CcSEcCtD
Cilazapril—Fatigue—Prednisone—ankylosing spondylitis	0.000489	0.00166	CcSEcCtD
Cilazapril—Headache—Prednisolone—ankylosing spondylitis	0.000489	0.00166	CcSEcCtD
Cilazapril—Discomfort—Methotrexate—ankylosing spondylitis	0.000488	0.00166	CcSEcCtD
Cilazapril—Constipation—Prednisone—ankylosing spondylitis	0.000485	0.00164	CcSEcCtD
Cilazapril—Confusional state—Methotrexate—ankylosing spondylitis	0.000478	0.00162	CcSEcCtD
Cilazapril—Dizziness—Triamcinolone—ankylosing spondylitis	0.000475	0.00161	CcSEcCtD
Cilazapril—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000474	0.0016	CcSEcCtD
Cilazapril—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000467	0.00158	CcSEcCtD
Cilazapril—Asthenia—Dexamethasone—ankylosing spondylitis	0.000467	0.00158	CcSEcCtD
Cilazapril—Asthenia—Betamethasone—ankylosing spondylitis	0.000467	0.00158	CcSEcCtD
Cilazapril—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000464	0.00157	CcSEcCtD
Cilazapril—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000464	0.00157	CcSEcCtD
Cilazapril—Nausea—Prednisolone—ankylosing spondylitis	0.000464	0.00157	CcSEcCtD
Cilazapril—Pruritus—Betamethasone—ankylosing spondylitis	0.000461	0.00156	CcSEcCtD
Cilazapril—Pruritus—Dexamethasone—ankylosing spondylitis	0.000461	0.00156	CcSEcCtD
Cilazapril—Skin disorder—Methotrexate—ankylosing spondylitis	0.00046	0.00156	CcSEcCtD
Cilazapril—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000458	0.00155	CcSEcCtD
Cilazapril—Vomiting—Triamcinolone—ankylosing spondylitis	0.000456	0.00155	CcSEcCtD
Cilazapril—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000455	0.00154	CcSEcCtD
Cilazapril—Rash—Triamcinolone—ankylosing spondylitis	0.000453	0.00153	CcSEcCtD
Cilazapril—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000452	0.00153	CcSEcCtD
Cilazapril—Anorexia—Methotrexate—ankylosing spondylitis	0.000452	0.00153	CcSEcCtD
Cilazapril—Rash—Methylprednisolone—ankylosing spondylitis	0.000452	0.00153	CcSEcCtD
Cilazapril—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000451	0.00153	CcSEcCtD
Cilazapril—Urticaria—Prednisone—ankylosing spondylitis	0.000451	0.00153	CcSEcCtD
Cilazapril—Headache—Triamcinolone—ankylosing spondylitis	0.00045	0.00152	CcSEcCtD
Cilazapril—Headache—Methylprednisolone—ankylosing spondylitis	0.000449	0.00152	CcSEcCtD
Cilazapril—Abdominal pain—Prednisone—ankylosing spondylitis	0.000448	0.00152	CcSEcCtD
Cilazapril—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000446	0.00151	CcSEcCtD
Cilazapril—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000446	0.00151	CcSEcCtD
Cilazapril—Hypotension—Methotrexate—ankylosing spondylitis	0.000443	0.0015	CcSEcCtD
Cilazapril—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000432	0.00146	CcSEcCtD
Cilazapril—Dizziness—Betamethasone—ankylosing spondylitis	0.000431	0.00146	CcSEcCtD
Cilazapril—Dizziness—Dexamethasone—ankylosing spondylitis	0.000431	0.00146	CcSEcCtD
Cilazapril—Insomnia—Methotrexate—ankylosing spondylitis	0.000429	0.00145	CcSEcCtD
Cilazapril—Nausea—Triamcinolone—ankylosing spondylitis	0.000426	0.00144	CcSEcCtD
Cilazapril—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000426	0.00144	CcSEcCtD
Cilazapril—Nausea—Methylprednisolone—ankylosing spondylitis	0.000425	0.00144	CcSEcCtD
Cilazapril—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000423	0.00143	CcSEcCtD
Cilazapril—Somnolence—Methotrexate—ankylosing spondylitis	0.000421	0.00143	CcSEcCtD
Cilazapril—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000418	0.00142	CcSEcCtD
Cilazapril—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000417	0.00141	CcSEcCtD
Cilazapril—Vomiting—Betamethasone—ankylosing spondylitis	0.000414	0.0014	CcSEcCtD
Cilazapril—Vomiting—Dexamethasone—ankylosing spondylitis	0.000414	0.0014	CcSEcCtD
Cilazapril—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000412	0.0014	CcSEcCtD
Cilazapril—Rash—Dexamethasone—ankylosing spondylitis	0.000411	0.00139	CcSEcCtD
Cilazapril—Rash—Betamethasone—ankylosing spondylitis	0.000411	0.00139	CcSEcCtD
Cilazapril—Dermatitis—Betamethasone—ankylosing spondylitis	0.00041	0.00139	CcSEcCtD
Cilazapril—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00041	0.00139	CcSEcCtD
Cilazapril—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000409	0.00139	CcSEcCtD
Cilazapril—Fatigue—Methotrexate—ankylosing spondylitis	0.000409	0.00138	CcSEcCtD
Cilazapril—Headache—Dexamethasone—ankylosing spondylitis	0.000408	0.00138	CcSEcCtD
Cilazapril—Headache—Betamethasone—ankylosing spondylitis	0.000408	0.00138	CcSEcCtD
Cilazapril—Asthenia—Prednisone—ankylosing spondylitis	0.000407	0.00138	CcSEcCtD
Cilazapril—Pain—Methotrexate—ankylosing spondylitis	0.000405	0.00137	CcSEcCtD
Cilazapril—Pruritus—Prednisone—ankylosing spondylitis	0.000401	0.00136	CcSEcCtD
Cilazapril—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000391	0.00132	CcSEcCtD
Cilazapril—Diarrhoea—Prednisone—ankylosing spondylitis	0.000388	0.00131	CcSEcCtD
Cilazapril—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000388	0.00131	CcSEcCtD
Cilazapril—Nausea—Dexamethasone—ankylosing spondylitis	0.000387	0.00131	CcSEcCtD
Cilazapril—Nausea—Betamethasone—ankylosing spondylitis	0.000387	0.00131	CcSEcCtD
Cilazapril—Urticaria—Methotrexate—ankylosing spondylitis	0.000377	0.00128	CcSEcCtD
Cilazapril—Dizziness—Prednisone—ankylosing spondylitis	0.000375	0.00127	CcSEcCtD
Cilazapril—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000375	0.00127	CcSEcCtD
Cilazapril—Vomiting—Prednisone—ankylosing spondylitis	0.000361	0.00122	CcSEcCtD
Cilazapril—Rash—Prednisone—ankylosing spondylitis	0.000358	0.00121	CcSEcCtD
Cilazapril—Dermatitis—Prednisone—ankylosing spondylitis	0.000357	0.00121	CcSEcCtD
Cilazapril—Headache—Prednisone—ankylosing spondylitis	0.000355	0.0012	CcSEcCtD
Cilazapril—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000349	0.00118	CcSEcCtD
Cilazapril—Asthenia—Methotrexate—ankylosing spondylitis	0.00034	0.00115	CcSEcCtD
Cilazapril—Nausea—Prednisone—ankylosing spondylitis	0.000337	0.00114	CcSEcCtD
Cilazapril—Pruritus—Methotrexate—ankylosing spondylitis	0.000335	0.00114	CcSEcCtD
Cilazapril—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000324	0.0011	CcSEcCtD
Cilazapril—Dizziness—Methotrexate—ankylosing spondylitis	0.000313	0.00106	CcSEcCtD
Cilazapril—Vomiting—Methotrexate—ankylosing spondylitis	0.000301	0.00102	CcSEcCtD
Cilazapril—Rash—Methotrexate—ankylosing spondylitis	0.000299	0.00101	CcSEcCtD
Cilazapril—Dermatitis—Methotrexate—ankylosing spondylitis	0.000299	0.00101	CcSEcCtD
Cilazapril—Headache—Methotrexate—ankylosing spondylitis	0.000297	0.00101	CcSEcCtD
Cilazapril—Nausea—Methotrexate—ankylosing spondylitis	0.000282	0.000954	CcSEcCtD
